Atlas Trials

3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease

Clinical trial NCT01374438 · COMPLETED

Trial details

NCT number
NCT01374438
Sponsor
Metabolic Solutions Development Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2011-07-01
Primary completion
2013-03-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.